Pluripotent stem cell-derived CAR-NK progenitor therapy targets minimal residual disease and prevents relapse in leukemia models

Cell stem cell 2026

View at publisher
Authors: Zhiqian Wang, Leqiang Zhang, Dehao Huang, Chengxiang Xia, Qitong Weng, Yunqing Lin, Yanhong Liu, Zhenghan Liu, Ruowen Yi, Fan Zhang, Yaoqin Zhao, Jiaxin Wu
+9 more Hanmeng Qi, Lijuan Liu, Yiyuan Shen, Yi Chen, Yanping Zhu, Tongjie Wang, Mengyun Zhang, Fangxiao Hu, Jinyong Wang
DOI: 10.1016/j.stem.2026.01.013
Cited by: 5
References: 41

Fields of Study & Subjects

Immune Cell Function and Interaction CAR-T cell therapy research Phagocytosis and Immune Regulation

Publication details

Journal / source
Cell stem cell
Publisher
Elsevier BV
Volume
33
Issue
3
Pages
405–420.e6
Publication date
24 February 2026
Language
EN